IQ-AI (IQAI) Competitors

GBX 1.48
+0.13 (+9.63%)
(As of 05/17/2024 ET)

IQAI vs. TRLS, FDBK, INHC, EVG, IXI, FAB, APTA, GDR, VAL, and HELD

Should you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Trellus Health (TRLS), Feedback (FDBK), Induction Healthcare Group (INHC), Evgen Pharma (EVG), IXICO (IXI), Fusion Antibodies (FAB), Aptamer Group (APTA), genedrive (GDR), ValiRx (VAL), and Hellenic Dynamics (HELD). These companies are all part of the "medical" sector.

IQ-AI vs.

IQ-AI (LON:IQAI) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, profitability, risk, institutional ownership, dividends, media sentiment, valuation and earnings.

IQ-AI received 6 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
IQ-AIOutperform Votes
6
66.67%
Underperform Votes
3
33.33%
Trellus HealthN/AN/A

IQ-AI has a beta of 2.91, suggesting that its share price is 191% more volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.1, suggesting that its share price is 90% less volatile than the S&P 500.

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IQ-AI£538.19K6.10N/AN/AN/A
Trellus Health£35K76.14-£6.34M-£0.03-55.00

2.4% of IQ-AI shares are held by institutional investors. Comparatively, 22.1% of Trellus Health shares are held by institutional investors. 35.8% of IQ-AI shares are held by company insiders. Comparatively, 57.7% of Trellus Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, IQ-AI had 1 more articles in the media than Trellus Health. MarketBeat recorded 1 mentions for IQ-AI and 0 mentions for Trellus Health. IQ-AI's average media sentiment score of 0.71 beat Trellus Health's score of 0.00 indicating that IQ-AI is being referred to more favorably in the media.

Company Overall Sentiment
IQ-AI Positive
Trellus Health Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IQ-AI
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Trellus Health has a net margin of 0.00% compared to IQ-AI's net margin of -102.37%. Trellus Health's return on equity of -28.43% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
IQ-AI-102.37% -155.57% -26.37%
Trellus Health N/A -28.43%-18.41%

Summary

IQ-AI and Trellus Health tied by winning 6 of the 12 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IQAI vs. The Competition

MetricIQ-AIHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£3.28M£255.32M£5.08B£1.50B
Dividend Yield17.30%6.40%37.18%8.52%
P/E Ratio-13.67613.99163.641,801.02
Price / Sales6.10632.812,326.29325,159.08
Price / Cash10.2541.8936.2634.21
Price / BookN/A5.465.712.79
Net IncomeN/A-£4.07M£104.88M£184.63M
7 Day Performance-10.30%0.07%1.90%1.06%
1 Month Performance-1.33%0.38%4.21%4.49%
1 Year Performance-48.07%-5.82%6.45%10.17%

IQ-AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
0 of 5 stars
GBX 1.65
flat
N/A-72.0%£2.67M£35,000.00-55.0031
FDBK
Feedback
0 of 5 stars
GBX 75
-3.2%
N/A-37.5%£10.00M£1.02M-288.4624Gap Down
INHC
Induction Healthcare Group
0 of 5 stars
GBX 12
-4.0%
N/A-44.4%£11.09M£11.82M-80.0083Gap Down
EVG
Evgen Pharma
0 of 5 stars
GBX 0.80
flat
N/A-79.2%£3.42MN/A-80.0010
IXI
IXICO
0 of 5 stars
GBX 7.38
flat
N/A-63.1%£3.57M£6.67M-368.7589News Coverage
FAB
Fusion Antibodies
0 of 5 stars
GBX 3.40
flat
N/A-90.9%£3.24M£1.58M-37.7848Gap Down
APTA
Aptamer Group
0 of 5 stars
GBX 0.83
+9.3%
N/A-94.1%£3.86M£1.03M-10.3137Gap Down
High Trading Volume
GDR
genedrive
0 of 5 stars
GBX 2
-20.0%
N/A-91.4%£2.86M£49,000.00-40.0043Gap Down
High Trading Volume
VAL
ValiRx
0 of 5 stars
GBX 3.05
flat
N/A-77.4%£4.04MN/A-101.678News Coverage
HELD
Hellenic Dynamics
0 of 5 stars
GBX 2.08
+4.0%
N/AN/A£2.73MN/A0.00N/AHigh Trading Volume

Related Companies and Tools

This page (LON:IQAI) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners